共 50 条
- [4] High-dose methotrexate combined with rituximab improves the survival rate of patients with primary central nervous system lymphoma [J]. JOURNAL OF BUON, 2021, 26 (02): : 366 - 372
- [10] White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab [J]. Journal of Neuro-Oncology, 2019, 145 : 461 - 466